This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
April 25, 2011 /PRNewswire/ -- Tibet Pharmaceuticals, Inc. (NASDAQ: TBET), an emerging specialty pharmaceutical company engaged in the development, today announces the release of a white paper on the traditional Tibetan medicine industry in
China, by market analyst
Arthur Goldgaber of SmallcapInsights.com.
Entitled "Traditional Tibetan Medicine: New Markets for Tibet's Ancient Therapies," the white paper describes the history of traditional Tibetan medicines in
China and the differences between their use and that of Western medicine. The paper also describes the expanding size of the Tibetan medicine industry in
China and how it has evolved into significant niche within the larger Traditional Chinese Medicine ("TCM") industry.
From the white paper, "One major component of the increased demand for both OTC products and pharmaceuticals is an aging Chinese population. By 2030,
China is expected to have the largest absolute number of elderly (aged over 65) in the world, totaling 222 million from 130 million in 2010 and will account for 15.9% of
China's total population, up from 9.7% in 2010."
The paper goes on to say, "
China's Tibetan medicine industry was about
RMB 1 billion (
$153 million) in size in 2006, about 0.5% of
China's total pharmaceutical industry, according to CMSN. The Tibetan medicine industry is believed to be growing rapidly: CMSN projected the Tibetan medicine industry as a whole to be growing at an average annual rate of about 50%."
The publication of the white paper is a part of Tibet Pharmaceuticals' continuing investor outreach and education program. To view the full white paper (free of charge, in PDF format), please visit:
www.tibetpharmaceuticals.com/res.htmlAbout Tibet Pharmaceuticals, Inc.
Based in Shangri-La County,
China, Tibet Pharmaceuticals, Inc. (NASDAQ: TBET) is a rapidly growing specialty pharmaceutical company engaged in the research, development, manufacturing and marketing of modernized traditional Tibetan medicines in
China. With over 190 full-time employees and nation-wide distributors, the company develops both prescription and over-the-counter traditional Tibetan medicines that promote health in human respiratory, digestive, urinary and reproductive systems. Tibet Pharmaceuticals' products are sold throughout
China, with a majority of sales concentrated in the southern provinces, most notably
Yunnan Province, where the company's 52,000 sq. ft. GMP-certified manufacturing facilities are located. The access to key raw materials, not generally available outside the province, provides a significant advantage for Tibet Pharmaceuticals.
For more information on Tibet Pharmaceuticals, please visit: